Arthur Smerling is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary hypertension. With a total of 2 patents to his name, Smerling's work focuses on innovative methods to improve patient outcomes.

Latest Patents

Smerling's latest patents include a groundbreaking method of inducing vasorelaxation to treat pulmonary hypertension. This invention provides a method of selectively decreasing pulmonary vascular resistance in a subject by administering endobronchially a drug chosen from among cAMP analogs, cGMP analogs, phosphodiesterase inhibitors, nitric oxide precursors, nitric oxide donors, and nitric oxide analogs. This innovative approach has the potential to significantly enhance treatment options for patients suffering from this condition.

Career Highlights

Arthur Smerling is affiliated with Columbia University, where he continues to advance his research and contribute to the academic community. His work is characterized by a commitment to developing effective therapeutic strategies that address critical health issues.

Collaborations

Smerling has collaborated with esteemed colleagues such as Charles A Lawson and David J Pinsky. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Arthur Smerling is a dedicated inventor whose work in pulmonary hypertension treatment exemplifies innovation in medicine. His contributions are paving the way for improved therapeutic methods that can benefit many patients.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]